Luciferase reporter mycobacteriophage (TM4::<i>GeNL</i>) enables rapid assessment of drug susceptibilities and inducible macrolide resistance in <i>Mycobacterium abscessus</i> complex.

J Clin Microbiol · 2025 · PMC12421814 · PMID 40833127

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an increasing trendno p-value reported

Since CLR susceptibility is a strong predictor of treatment outcome among MAB infections, an increasing trend of CLR resistance, including inducible resistance, is alarming, and early identification is empirical for treating MAB infections ( 36 , 37 ).

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.

Luciferase reporter mycobacteriophage (TM4::&lt;i&gt;GeNL&lt;/i&gt;) enables rapid assessment of drug susceptibilities and inducible macrolide resistance in &lt;i&gt;Mycobacterium abscessus&lt;/i&gt; complex.

The sentences

Luciferase reporter mycobacteriophage (TM4::<i>GeNL</i>) enables rapid assessment of drug susceptibilities and inducible macrolide resistance in <i>Mycobacterium abscessus</i> complex.